Actual Medicinal Product (AMP) -
COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials (Sanofi)
Name Details
|
Current Name
COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials
|
Start Date
10-01-2023
|
End Date
|
|
Previous Name
COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose emulsion for injection multidose vials
|
Start Date
04-08-2022
|
End Date
09-01-2023
|
|
|
Abbreviated Name
COVID-19 Vacc VidPrevtyn (B.1.351) 0.5ml inj multidose vials
|
Start Date
10-01-2023
|
|
| COVID-19 Vacc Sanofi (B.1.351) 0.5ml inj multidose vials |
Previous Start Date
04-08-2022
|
Previous End Date
09-01-2023
|
Summary
- Licensed Route
- Intramuscular
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 40872011000001104 |
04-08-2022 |
|
Actual Medicinal Product Pack (AMPP) Information